Belanova A.A. Effects of JUN and NFE2L2 knockdown on oxidative status and NFE2L2/AP-1 targets expression in HeLa cells in basal conditions and upon sub-lethal hydrogen peroxide treatment / Belanova A.A., Chmyhalo V.K., Makarenko M.S., Lyangasova O.V., Belousova MM, Aleksandrova A.A., Zolotukhin P.V. // Molecular Biology Reports. — 2019. — Vol. 46, № 1. URL: doi: 10.1007/s11033-018-4412-4

Belanova A.A. Berberine Effects on NFkB, HIF1A and NFE2L2/AP-1 Pathways in HeLa Cells / Belanova A.A., Beseda D, Chmyhalo V.K., Stepanova A, Belousova M, Khrenkova V, Gavalas N, Zolotukhin P.V. // Anti-Cancer Agents in Medicinal Chemistry. — 2019. — Vol. 19, № 4. URL: DOI: 10.2174/1871520619666181211121405

Zolotukhin P.V. Chemistry, biochemistry and signaling: the NFE2L2/AP-1 pathway / Zolotukhin P.V., Belanova A.A., Beseda D.K., Prazdnova E.V., Chistyakov VA // Periodico tche quimica. — 2018. — T. 15 — С. 103-111.

Kaydashev V.E. Macroscopic monolayer of plasmon coupled gold nanoparticles on mirror for fluorescence enhancement / Kaydashev V.E., Zolotukhin P.V., Belanova A.A., Anokhin A.S., Zharinov V.S., Kaidashev E.M. // Saratov Fall Meeting 2017: optical technologies in biophysics and medicine XIX. — 2018. — Vol. 10716, URL: DOI: 10.1117/12.2315071

Belanova A.A. Physicochemical Properties of Magnetic Nanoparticles: Implications for Biomedical Applications In Vitro and In Vivo / Belanova A.A., Gavalas N., Makarenko Yu.M., Belousova M.M., Soldatov A.V., Zolotukhin P.V. // Oncology research and treatment. — 2018. — Vol. 41, № 3. URL: DOI: 10.1159/000485020